363 top medical experts on Neonatal Hyperbilirubinemia across 54 countries and 31 U.S. states, including 217 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Neonatal Hyperbilirubinemia: Accumulation of bilirubin, a breakdown product of heme proteins, in the blood during the first weeks of life. This may lead to neonatal jaundice. The excess bilirubin may exist in the unconjugated (indirect) or the conjugated (direct) form. The condition may be self-limiting (physiological neonatal jaundice) or pathological with toxic levels of bilirubin.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Diseases Newborn Infant (2,780), Hyperbilirubinemia (2,722) and Narrower Categories: Neonatal Jaundice (1,852).
  4. Clinical Trials ClinicalTrials.gov : at least 57 including 1 Active, 29 Completed, 8 Recruiting


  

        

                    


    Computing Expert Listing ...

);